CRAI Stock Analysis: CRA International | NASDAQ

Consulting Services | NASDAQ, USA | Market Cap: 1.109m USD | 12M Return: 0.2% | US12618T1051 | Charts, Fundamentals & Technical Analysis

Economic Analysis, Litigation Support, Management Advisory, Forensic Accounting
Total Rating 55
Safety 80
Buy Signal -0.18
Consulting Services
Industry Rotation: +14.5
Market Cap: 1.11B
Avg Turnover: 20.6M
Risk 3d forecast
Volatility34.9%
VaR 5th Pctl5.85%
VaR vs Median1.75%
Choppyness75.5%
Reward TTM
Sharpe Ratio0.09
Rel. Str. IBD46.2
Rel. Str. Peer Group51.8
Character TTM
Beta-0.062
Beta Downside-0.032
Hurst Exponent0.529
Drawdowns 3y
Max DD38.12%
CAGR/Max DD0.61
CAGR/Mean DD1.91
EPS (Earnings per Share) EPS (Earnings per Share) of CRAI over the last years for every Quarter: "2021-09": 1.44, "2021-12": 1.14, "2022-03": 1.53, "2022-06": 1.58, "2022-09": 1.64, "2022-12": 1.19, "2023-03": 1.29, "2023-06": 1.42, "2023-09": 1.13, "2023-12": 1.63, "2024-03": 1.96, "2024-06": 1.83, "2024-09": 1.77, "2024-12": 2.03, "2025-03": 2.22, "2025-06": 1.88, "2025-09": 2.06, "2025-12": 2.06, "2026-03": 1.99, "2026-06": 2.16,
EPS CAGR: 18.86%
EPS Trend: 91.4%
Last SUE: 0.25
Qual. Beats: 0
Revenue Revenue of CRAI over the last years for every Quarter: 2021-09: 136.412, 2021-12: 134.766, 2022-03: 148.382, 2022-06: 149.102, 2022-09: 148.441, 2022-12: 144.976, 2023-03: 152.845, 2023-06: 161.965, 2023-09: 147.553, 2023-12: 161.613, 2024-03: 171.789, 2024-06: 171.442, 2024-09: 167.748, 2024-12: 176.435, 2025-03: 181.851, 2025-06: 186.878, 2025-09: 185.891, 2025-12: 196.963, 2026-03: 200.975, 2026-06: 210.815,
Rev. CAGR: 9.84%
Rev. Trend: 99.8%
Last SUE: 4.00
Qual. Beats: 5

Warnings

Choppy

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan -3.2% 35
Feb +2.5% 20
Mar -0.2% 18
Apr +1.6% 13
May -6.1% 17
Jun -0.4% 5
Jul +2.3% 29
Aug -1.1% 5
Sep -1.4% 14
Oct +1.5% 0
Nov +1.6% 34
Dec -0.0% 2

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: CRAI CRA International

CRA International, Inc. (NASDAQ: CRAI) is a global consulting firm specializing in economic, financial, and management advisory services. The company operates through two core practice areas: litigation and regulatory consulting-where it provides expert testimony, forensic accounting, and research support to attorneys and corporate clients-and management consulting, which covers strategy development, performance improvement, ESG and sustainability advisory, auction and bidding design, intellectual property valuation, and market research. CRAI serves a broad range of industries, including blockchain and cryptocurrency, communications and media, energy, financial services, healthcare, life sciences, manufacturing, technology, and transportation, reflecting a diversified client base. The company was founded in 1965 and is headquartered in Boston, Massachusetts.

CRAI operates within the Research & Consulting Services sub-industry (GICS: Industrials), a sector characterized by project-based engagements, professional-services billing models, and reliance on highly credentialed expert staff. Its positioning across both litigation support and corporate strategy consulting allows it to generate revenue from law firms and regulators on one side and from corporate strategy and operational decisions on the other.

Headlines to Watch Out For
  • Litigation consulting demand drives expert testimony revenue growth
  • ESG and sustainability strategy consulting expands across industries
  • Energy and healthcare sector engagements offset financial services weakness
Piotroski VR-10 (Strict) 5.0
Net Income: 49.3m TTM > 0 and > 6% of Revenue
FCF/TA: -0.04 > 0.02 and ΔFCF/TA -7.65 > 1.0
NWC/Revenue: 2.38% < 20% (prev -3.40%; Δ 5.78% < -1%)
CFO/TA -0.03 > 3% & CFO -21.7m > Net Income 49.3m
Net Debt (260.6m) to EBITDA (106.3m): 2.45 < 3
Current Ratio: 1.06 > 1.5 & < 3
Outstanding Shares: last quarter (6.41m) vs 12m ago -5.12% < -2%
Gross Margin: 26.80% > 18% (prev 32.02%; Δ -5.22% > 0.5%)
Asset Turnover: 124.9% > 50% (prev 117.5%; Δ 7.45% > 0%)
Interest Coverage Ratio: 10.91 > 6 (EBIT TTM 77.4m / Interest Expense TTM 7.10m)
Altman Z'' 2.34
A: 0.03 (Total Current Assets 349.0m - Total Current Liabilities 330.0m) / Total Assets 665.3m
B: 0.29 (Retained Earnings 192.2m / Total Assets 665.3m)
C: 0.12 (EBIT TTM 77.4m / Avg Total Assets 636.0m)
D: 0.38 (Book Value of Equity 182.7m / Total Liabilities 482.4m)
Altman-Z'' = 2.34 = BBB
Beneish M -2.79
DSRI: 0.94 (Receivables 265.6m/253.0m, Revenue 794.6m/712.9m)
GMI: 1.19 (GM 32.02% / 26.80%)
AQI: 1.02 (AQ_t 0.32 / AQ_t-1 0.31)
SGI: 1.11 (Revenue 794.6m / 712.9m)
TATA: 0.11 (NI 49.3m - CFO -21.7m) / TA 665.3m)
Beneish M = -2.79 (Cap -4..+1) = A
What is the price of CRAI shares?

As of October 15, 2026, the stock is trading at USD 175.57 with a total of 132,165 shares traded. Over the past week, the price has changed by +0.36%, over one month by +5.78%, over three months by +7.33% and over the past year by +0.24%.

Current recommended Stop Loss: 162.20 (which is 7.6% or 2.5 ATR below the current price).

Is CRAI a buy, sell or hold?

CRA International has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold CRAI.

  • StrongBuy: 0
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the CRAI price?
Analysts Target Price 250.5 42.7%
CRA International (CRAI) - Fundamental Data Overview as of 13 October 2026
Market Cap USD = 1.11b (1.11b USD * 1.0 USD.USD)
P/E Trailing = 23.564
P/E Forward = 17.0068
P/S = 1.396
P/B = 5.6038
P/EG = 1.0631
Revenue TTM = 794.6m USD
EBIT TTM = 77.4m USD
EBITDA TTM = 106.3m USD
Long Term Debt = 143.0m USD (estimated: total debt 194.2m - short term 51.2m)
Short Term Debt = 51.2m USD (from shortTermDebt, last quarter)
Debt = 278.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 84.7m
Net Debt = 260.6m USD (calculated: Debt 278.8m - CCE 18.2m)
Enterprise Value = 1.37b USD (1.11b + Debt 278.8m - CCE 18.2m)
Interest Coverage Ratio = 10.91 (Ebit TTM 77.4m / Interest Expense TTM 7.10m)
EV/FCF = -49.37x (Enterprise Value 1.37b / FCF TTM -27.7m)
FCF Yield = -2.03% (FCF TTM -27.7m / Enterprise Value 1.37b)
FCF Margin = -3.49% (FCF TTM -27.7m / Revenue TTM 794.6m)
Net Margin = 6.20% (Net Income TTM 49.3m / Revenue TTM 794.6m)
Gross Margin = 26.80% ((Revenue TTM 794.6m - Cost of Revenue TTM 581.7m) / Revenue TTM)
Gross Margin QoQ = 29.45% (prev 26.15%)
Tobins Q-Ratio = 2.06 (Enterprise Value 1.37b / Total Assets 665.3m)
Interest Expense / Debt = 2.55% (Interest Expense 7.10m / Debt 278.8m)
Taxrate = 31.84% (23.0m / 72.3m)
NOPAT = 52.8m (EBIT 77.4m * (1 - 31.84%))
Current Ratio = 1.06 (Total Current Assets 349.0m / Total Current Liabilities 330.0m)
Debt / Equity = 1.53 (Debt 278.8m / totalStockholderEquity, last quarter 182.7m)
Debt / EBITDA = 2.45 (Net Debt 260.6m / EBITDA 106.3m)
 Debt / FCF = -9.39 (negative FCF - burning cash) (Net Debt 260.6m / FCF TTM -27.7m)
 Total Stockholder Equity = 199.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.75% (Net Income 49.3m / Total Assets 665.3m)
RoE = 24.76% (Net Income TTM 49.3m / Total Stockholder Equity 199.1m)
RoCE = 22.63% (EBIT 77.4m / Capital Employed (Equity 199.1m + L.T.Debt 143.0m))
RoIC = 14.33% (NOPAT 52.8m / Invested Capital 368.2m)
WACC = 4.95% (E(1.11b)/V(1.39b) * Re(5.76%) + D(278.8m)/V(1.39b) * Rd(2.55%) * (1-Tc(0.32)))
Discount Rate = 5.76% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.00 | Cagr: -3.92%
 [DCF] Fair Price = unknown (Cash Flow -27.7m)
 EPS Correlation: 91.38 | EPS CAGR: 18.86% | SUE: 0.25 | # QB: 0
Revenue Correlation: 99.83 | Revenue CAGR: 9.84% | SUE: 4.0 | # QB: 5
EPS current Quarter (2026-09-30): EPS=2.07 | Chg30d=+0.00% | Revisions=-50% | Analysts=3
EPS current Year (2026-12-31): EPS=8.47 | Chg30d=+0.00% | Revisions=-17% | GrowthEPS=+2.9% | GrowthRev=+8.3%
EPS next Year (2027-12-31): EPS=9.56 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+12.9% | GrowthRev=+4.0%
[Analyst] Revisions Ratio: -36% (up=2, down=6)